Table 1 Patients’ Demographic and Clinicopathological Data
From: E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway
CHARACTERISTIC | Number (%) of cases |
|---|---|
Age | |
40–59 | 75 (34.7%) |
60–79 | 130 (60.2%) |
> 80 | 11 (5.1%) |
Gender | |
Male | 119 (55.1%) |
Female | 97 (44.9%) |
Tumor histology | |
Tubular adenocarcinoma | 126 (58.3%) |
Mucinous adenocarcinoma | 74 (34.3%) |
Papillary adenocarcinoma | 16 (7.4%) |
Tumor site | |
Rectum and sigmoid | 97 (44.9%) |
Right colon | 94 (43.5%) |
Left colon | 25 (11.6%) |
Tumor size | |
≤ 5 cm | 103 (47.7%) |
> 5 cm | 113 (52.3%) |
TNM stage | |
I | 57 (26.4%) |
II | 62 (28.7%) |
III | 80 (37.0%) |
IV | 17 (7.9%) |